cyproterone acetate has been researched along with Cancer, Second Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elvira, R; Guijarro, G; Montoya, T; Olivar, J | 1 |
| Culine, S; Droz, JP; Elias, D; Kattan, J; Spatz, A; Terrier-Lacombe, MJ | 1 |
1 review(s) available for cyproterone acetate and Cancer, Second Primary
| Article | Year |
|---|---|
Hepatocellular carcinoma during hormonotherapy for prostatic cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cyproterone Acetate; Humans; Liver Neoplasms; Male; Neoplasms, Second Primary; Prostatic Neoplasms; Triptorelin Pamoate | 1994 |
1 other study(ies) available for cyproterone acetate and Cancer, Second Primary
| Article | Year |
|---|---|
[Virilization of a post-menopausal woman. Diagnostic and therapeutic considerations].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Androgens; Carcinoma, Transitional Cell; Cyproterone Acetate; Dexamethasone; Diagnosis, Differential; False Negative Reactions; Female; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Incidental Findings; Neoplasms, Second Primary; Ovarian Diseases; Postmenopause; Triptorelin Pamoate; Urinary Bladder Neoplasms; Virilism | 2009 |